BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26388956)

  • 1. Methylome profiling reveals functions and genes which are differentially methylated in serrated compared to conventional colorectal carcinoma.
    Conesa-Zamora P; García-Solano J; Turpin Mdel C; Sebastián-León P; Torres-Moreno D; Estrada E; Tuomisto A; Wilce J; Mäkinen MJ; Pérez-Guillermo M; Conesa A
    Clin Epigenetics; 2015; 7(1):101. PubMed ID: 26388956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two histologically colorectal carcinomas subsets from the serrated pathway show different methylome signatures and diagnostic biomarkers.
    García-Solano J; Turpin MC; Torres-Moreno D; Huertas-López F; Tuomisto A; Mäkinen MJ; Conesa A; Conesa-Zamora P
    Clin Epigenetics; 2018 Nov; 10(1):141. PubMed ID: 30413173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma.
    Conesa-Zamora P; García-Solano J; García-García F; Turpin Mdel C; Trujillo-Santos J; Torres-Moreno D; Oviedo-Ramírez I; Carbonell-Muñoz R; Muñoz-Delgado E; Rodriguez-Braun E; Conesa A; Pérez-Guillermo M
    Int J Cancer; 2013 Jan; 132(2):297-307. PubMed ID: 22696308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Methylome Scores Correlate with Histological Subtypes of Colorectal Carcinoma and Show Different Associations with Common Clinical and Molecular Features.
    Turpín-Sevilla MDC; Pérez-Sanz F; García-Solano J; Sebastián-León P; Trujillo-Santos J; Carbonell P; Estrada E; Tuomisto A; Herruzo I; Fennell LJ; Mäkinen MJ; Rodríguez-Braun E; Whitehall VLJ; Conesa A; Conesa-Zamora P
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in gene expression profiling and biomarkers between histological colorectal carcinoma subsets from the serrated pathway.
    García-Solano J; Turpin-Sevilla MDC; García-García F; Carbonell-Muñoz R; Torres-Moreno D; Conesa A; Conesa-Zamora P
    Histopathology; 2019 Oct; 75(4):496-507. PubMed ID: 31025430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal serrated adenocarcinoma.
    Mäkinen MJ
    Histopathology; 2007 Jan; 50(1):131-50. PubMed ID: 17204027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas.
    García-Solano J; Conesa-Zamora P; Carbonell P; Trujillo-Santos J; Torres-Moreno D D; Pagán-Gómez I; Rodríguez-Braun E; Pérez-Guillermo M
    Int J Cancer; 2012 Oct; 131(8):1790-9. PubMed ID: 22287190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 3 iodothyronine deiodinase in neonatal goats: molecular cloning, expression, localization, and methylation signature.
    Zhong T; Jin PF; Zhao W; Wang LJ; Li L; Zhang HP
    Funct Integr Genomics; 2016 Jul; 16(4):419-28. PubMed ID: 27108114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide methylation profiling of early colorectal cancer using an Illumina Infinium Methylation EPIC BeadChip.
    Wu YL; Jiang T; Huang W; Wu XY; Zhang PJ; Tian YP
    World J Gastrointest Oncol; 2022 Apr; 14(4):935-946. PubMed ID: 35582104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.
    Laiho P; Kokko A; Vanharanta S; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Karttunen TJ; Tuppurainen K; Davalos V; Schwartz S; Arango D; Mäkinen MJ; Aaltonen LA
    Oncogene; 2007 Jan; 26(2):312-20. PubMed ID: 16819509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum DNA methylome of the colorectal cancer serrated pathway enables non-invasive detection.
    Gallardo-Gómez M; Costas-Ríos L; Garcia-Prieto CA; Álvarez-Rodríguez L; Bujanda L; Barrero M; Castells A; Balaguer F; Jover R; Esteller M; Tardío Baiges A; González-Carreró Fojón J; Cubiella J; De Chiara L
    Mol Oncol; 2023 Dec; ():. PubMed ID: 38129291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
    APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
    Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
    Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
    Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway.
    Bae JM; Kim JH; Rhee YY; Cho NY; Kim TY; Kang GH
    World J Gastroenterol; 2015 Sep; 21(33):9749-57. PubMed ID: 26361422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.